Therapy of Chronic Myocardial Tissue Heart Insufficiency
CardAPcells are cultivated using the patients‘ own cells: Cells derived from heart tissue for the novel proprietary therapy of chronic myocardial heart insufficiency
Step 1
Biopsy
A biopsy is performed. A very small portion of the patient’s heart muscle tissue is extracted (usually from biopsy for regular laboratory testing)
Step 2
Isolation & Expansion
The cells from the collected tissue are cultivated externally in a GMP* laboratory, until the desired amount has been reached
*GMP = good manufacturing practice (highest clean room requirements)
Step 3
Intravenous or intramyocardial injection
The cultivated cells are injected back into the patient
Since the patient receives his/her “own” cells, complications such as rejection by the immune system (common with heart transplants) or allergic reactions (possible with drug therapies) are unlikely